Regulation of the specific DNA binding activity of Xenopus laevis p53: Evidence for conserved regulation through the carboxy-terminus of the protein

Oncogene

Volumn 16, Issue 7, 1998, Pages 883-890

  Bessard, Anne Claire Hardy ^a,c   Garay, Edith ^a,d   Lacronique, Virginie ^a   Legros, Yann ^a,e   Demarquay, Christel ^a   Houque, Armelle ^a   Portefaix, Jean Michel ^b   Granier, Claude ^b   Soussi, Thierry ^a,f  

^a INSERM   (France)

^b CNRS   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^e Parc Technologique   (France)

^f INSTITUT CURIE   (France)

Author keywords

Manoclonal antibodies; p53; Transactivation; Xenopus

Indexed keywords

MONOCLONAL ANTIBODY; POLYLYSINE; PROTEIN P53; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA BINDING; ESCHERICHIA COLI; GENETIC CONSERVATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; XENOPUS LAEVIS;

AMPHIBIA; ANIMALIA; ANURA; ESCHERICHIA COLI; INSECTA; REPTILIA; XENOPUS LAEVIS;

EID: 0004623102     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201598     Document Type: Article

References (45)

1. Abarzula P, Losardo JE, Gubler ML and Neri A. (1995). Cancer Res., 55, 3490-3494.
2. Béroud C and Soussi T. (1997). Nucleic Acids Res., 25, 138.
3. Bischoff JR, Casso D and Beach D. (1992). Mol. Cell. Biol., 12, 1405-1411.
4. Buckbinder L, Talbott R, Velascomiguel S, Takenaka I, Faha B, Seizinger BR and Kley N. (1995). Nature, 377, 646-649.
5. Cho YJ, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
6. El-Deiry WS, Kern SE, Pientenpol JA, Kinzler KW and Vogelstein B. (1992). Nature Genetics, 1, 45-49.
7. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell. 75, 817-825.
8. Gannon JV, Greaves R, Iggo R and Lane DP. (1990). EMBO J., 9, 1595-1602.
9. Halazonetis TD, Davis LJ and Kandil AN. (1993). EMBO J., 12, 1021-1028.
10. Hall PA and Lane DP. (1997). Curr. Biol., 7, R144-R147.
11. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
12. Hupp TR and Lane DP. (1994). Cold Spring Harb Symp Quant Bio3, 59, 195-206.
13. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell. 71, 875-886.
14. Hupp TR, Sparks A and Lane DP. (1995). Cell, 83, 237-245.
15. Ishioka C, Englert C, Winge P, Yan YX, Engelstein M and Friend SH. (1995). Oncogene, 10, 1485-1492.
16. Jayaraman L, Murthy KGK, Zhu C, Curran T, Xanthoudakis S and Prives C. (1997). Gene Develop., 11, 558-570.
17. Jayaraman L and Prives C. (1995). Cell. 81, 1021-1029.
18. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
19. Kastan MB, Zhan QM, El-Deiry WS, Carrier F, Jacks T, Walsh WV. Plunkett BS, Vogelstein B and Fornace AJ. (1992). Cell, 71, 587-597.
20. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B. (1991). Science, 252, 1708-1711.
21. Kubbutat MHG, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
22. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP. (1996). Science, 274, 948-953.
23. Lane DP, Stephen CW, Midgley CA, Sparks A, Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B and Picksley SM. (1996). Oncogene, 12, 2461-2466.
24. Legros Y, Lacabanne V, D'Agay MF, Larsen CJ, Pla M and Soussi T. (1993). Bull. du Cancer, 80, 102-110.
25. Legros Y, Lafon C and Soussi T. (1994a). Oncogene, 9, 2071-2076.
26. Legros Y, Meyer A, Ory K and Soussi T. (1994b). Oncogene, 9, 3689-3694.
27. Marechal V, Elenbaas B, Taneyhill L, Piette J, Mechali M, Nicolas JC, Levine AJ and Moreau J. (1997). Oncogene, 14, 1427-1433.
28. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
29. Nigro JM, Sikorski R, Reed SI and Vogelstein B. (1992). Mol. Cell. Biol., 12, 1357-1365.
30. Okamoto K and Beach D. (1994). EMBO J., 13, 4816-4822.
31. Ory K, Legros Y, Auguin C and Soussi T. (1994). EMBO J., 13, 3496-3504.
32. Ridgway PJ, Soussi T and Braithwaite AW. (1994). J. Virol., 68, 7178-7187.
33. Shaulsky G, Goldfinger N, Benzeev A and Rotter V. (1990). Mol. Cell. Biol., 10, 6565-6577.
34. Shaw P, Freeman J, Bovey R and Iggo R. (1996). Oncogene, 12, 921-930.
35. Shivakumar CV, Brown DR, Deb S and Deb SP. (1995). Mol. Cell. Biol., 15, 6785-6793.
36. Soussi T, Caron de Fromentel C and May P. (1990). Oncogene, 5, 945-952.
37. Soussi T, Caron de Fromentel C, Méchali M, May P and Kress M. (1987). Oncogene, 1, 71-78.
38. Soussi T, Caron de Fromentel C, Stürzbecher HW, Ullrich S, Jenkins J & May P. (1989). J. Virol., 63, 3894-3901.
39. Soussi T and May P. (1996). J. Mol. Biol., 260, 623-637.
40. Tchang F, Gusse M, Soussi T and Méchali M. (1993). Dev. Biol., 159, 163-172.
41. Wagner P, Simanis V, Maimets T, Keenan E, Addison C, Brain R, Grimaldi M, Sturzbecher HW and Jenkins J. (1991). Oncogene, 6, 1539-1547.
42. Wang Y, Farmer G, Soussi T and Prives C. (1995). Oncogene, 10, 779-784.
43. Wu XW, Bayle JH, Olson D and Levine AJ. (1993). Gene Develop., 7, 1126-1132.
44. Zauberman A, Lupo A and Oren M. (1995). Oncogene, 10, 2361-2366.
45. Zhang W, Guo XY, Hu GY, Liu WB, Shay JW and Deisseroth AB. (1994). EMBO J., 13, 2535-2544.